Journal
NEUROSCIENCE
Volume 417, Issue -, Pages 45-56Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neuroscience.2019.08.017
Keywords
Alzheimer's disease; amyloidogenesis; 5xFAD mice; p35; Cdk5; Sex differences
Categories
Funding
- Faculty Research and Creative Endeavors grant from Central Michigan University
Ask authors/readers for more resources
Increased amyloid beta (Ab) deposition is implicated in early stages of Alzheimer's disease (AD). Although aberrant Cdk5 activity mediated by Cdk5/p25 is suggested to promote Ab plaque deposition, the effects of Cdk5 inhibition on Ab plaque loads in AD mouse models have been equivocal, possibly due to the fact that Cdk5 can be activated by p35 or p39 and their cleaved products. Here we evaluated the effect of p35 knockdown on Ab plaque formation by constitutively knocking out a single p35 allele in 5xFAD mice. Surprisingly, our results show that the simultaneous reduction in the levels of p35 and p25 increases cortical Ab plaque loads in male 5xFAD mice, but not in females. This change is associated with male specific decrease in pSer9 GSK3b levels. Furthermore, p35 hemizygous deletion has sexually dimorphic effects on Iba1 and GFAP protein levels. Our findings demonstrate sex differences in the effects of p35 reduction on biochemical pathways relevant to the modulation of Ab plaque deposition and confirm the importance of examining both sexes in preclinical AD research. (C) 2019 IBRO. Published by Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available